Explosives And Pyrotechnics Market: Construction Industry is going to Increased the Scope of this Market

The global Explosives Market is expected to reach USD 31.95 billion by 2024, according to a new report by Grand View Research, Inc. The global explosives and pyrotechnics market is expected to grow significantly over the forecast period on account of increasing use of the product in construction and mining activities.

Rising number of projects for infrastructure development in Asia Pacific is expected to drive the demand for explosives as a blasting agent. Increasing government spending for infrastructure development in Asia Pacific and the Middle East on account of increasing domestic output is expected to play a significant role in amplifying construction activities in these regions.

In 2013, Asia Pacific contributed to approximately 44% of the total global construction spending, an increase of 4% from the previous year. Also, the development of new construction and building projects in Asia is likely to boost market growth. The demand for explosives in the region is expected to be 14.93 million tons by 2024.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-explosives-pyrotechnics-market

Further key findings from the report suggest:

• Positive outlook towards the mining sector in Chile, and Peru, and owing to government policies to open opportunities for investments by foreign players, to improve the economic conditions, is expected to drive the demand for explosives subsequently. The segment is projected to witness volume growth at a CAGR of 4.9% over the forecast period.
• Coal mining was the largest application within the mining sector accounting for 49.8% of the volume in 2015. However, the outlook towards coal is likely to be bleak over the forecast period on account of increasing shifting trends of consumers towards alternative sources of energy including natural gas and renewable energy. However, metal mining is expected to witness tremendous growth on account of rising demand for metals including rare earth elements.
• Consumer pyrotechnics accounted for 36.2% of the global volume in 2015 and is expected to grow on account of increasing demand for recreational fireworks, model rocket motors, and powder-actuated nail guns.
• Key market players include Orica Mining Services, ENAEX, Maxam Corp., Sasol Limited, Austin Powder Company, AEL Mining Services, Chemring Group, Incitec Pivot, AECI Group, Pyro Company Fireworks, ePC Group, Alliant Techsystems, Titanobel SAS, Hanwha Corp., Solar Industries India, and LSB Industries.
• Companies are focusing on product innovation to cater to the growing demand for safe & effective explosives. For instance, in September 2016, Orica launched a new product, Vistis Bulk System, catering to the growing consumer demand in Australia.

Market Outlook of Global Nerve Repair and Regeneration Market Analysis and Foresight Report to 2024

The global Nerve Repair and Regeneration Market is expected to reach USD 15.7 billion by 2024, according to a new report by Grand View Research, Inc. The demand for neurological disorder devices and therapies is expected to exhibit an upsurge over the forecast period owing to the rising awareness, the increasing incidence rate, the favorable government funding and reimbursement policies, and the continual technological advances offered by the key players of the industry. According to the American Physiological Society, approximately 12,000 spinal Cord Injuries (SCI) are recorded every year in the U.S. The majority of these injuries take place due to sporting accidents, gunshot wounds, car accidents, and falls. 

In January 2016, The EU Horizon 2020 program funded a research project ‘AUTOSTEM’ launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI) amounting toUSD 6.73 million. This project is to develop a robotic stem cell production factory, involved in fully automated manufacturing of stem cells in large volumes; thus, having an edge over the old traditional techniques. Also, this technique will treat a range of therapies pertaining tocancer,arthritis, diabetes and other complications. 

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-nerve-repair-regeneration-market

Further key findings from the report suggest: 

• The neurostimulation and neuromodulation segment dominated the product segment of the market due to the increasing awareness about the devices coupled with the surgingnumber of central nervous system disorders in the population
• North America dominated the market in 2015 owing to the technological advancements in the region and the introduction of new devices by the manufacturers. In 2015, U.S proved to be the most potential market. The rise in number of cases withinjuries in the Central Nervous System (CNS), including injuries to the spinal cord and the brain,and increase in the governmentinitiatives and funding,as well as funding fromvarious other agencies were some of the major reasons responsible for the growth.
• According to the report published by the Florida University, annually,more than 2 million people sufferfromtraumatic injuries of the brain in the US and a minimum of 10,000 people suffered with spinal cord injuries.The CNS injuries are a consequence of incompletely elucidated biochemical pathological phenomenon. This lack of complete understanding in the field drives the urgency for ramping up R&D efforts to develop novel neurotherapeutic approaches.
• In March 2016, Baxter International, Inc. completed the CE marking, the indication for marketing of ‘HEMOPATCH’, the ready-to-use surgical patch in the European market. This patch was approved for use in dural defect repair, for treatingtraumatic injuries of the brain, CNS, andas a surgical sealant to contain leakage of bodily fluids in otherbody parts, oras a hemostatic device to prevent the loss of blood. 
• APAC is expected to be the fastest growing region of the nerve repair and regeneration market. Aging population, technological advancements, and unmet medical needs in this region are some of the reasons for the growth of the market
• In February 2016, Indian scientists working for Revita Life Sciences and Bioquark, Inc. gained permission to conduct clinical trials in 20 clinically dead patients to bring specific parts of their central nervous system back to life. Combination of therapies are to be applied including injecting the brain with stem cells, cocktail of peptides, use of lasers and nerve stimulation techniquesthat have been proven successful in reviving comatose patients.A blend of regenerative medicine tools and treatment devices are to be employed to achieve success with such a complex undertaking.

Premium Insights on Neuromorphic Computing Market 2024 with Regional Analysis and Key Industry Trends

The Neuromorphic Computing Market size is expected to reach USD 6,480.1 million by 2024 according to a new study by Grand View Research, Inc.

The global neuromorphic computing market is expected to gain traction, owing to the rising demand for artificial intelligence. The prominent industry vendors are focusing on the development of neural processing units that can be incorporated into the processor chip for the reverse-engineering of the human brain.

The rising demand for cognitive and brain robots are projected to impel growth in the industry. Neuromorphic chips facilitate users with several benefits such as high-performance speed, cognitive computing, optimum usage of memory, and low power consumption. The escalated demand in diverse industrial verticals, including consumer electronics, automotive, and robotics is instrumental in keeping the industry prospects upbeat.

The rise in the demand for aerial surveillance and satellite imagery is impelling growth in the industry. The growth in the audio and signal processing application segments is further presumed to positively impact the industry.

The growing demand in end-use segments, such as the automotive and military & defense sectors, is creating new avenues for industry expansion. However, the vendors need to make substantial investments in the research and development activities of neuroscience and computing before foraying into the industry. Replicating the neural patterns on chips requires the use of complex algorithms, which makes the design process more intricate.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-neuromorphic-computing-market

Further key findings from the study suggest:

• The consumer electronics end-use segment dominated the global neuromorphic computing industry, accounting for over 62% of the market share in 2016. The emerging trend of using brain computers and smart consumer wearable devices is favorably impacting the industry growth.
• The North American regional market accounted for 34% of the global revenue share in 2016. The strong presence of neuromorphic chip vendors in this region is expected to contribute to the industry growth in the region.
• The signal processing application segment accounted for 30% of the global revenue share in 2016. The increasing demand for processing acoustic and audio signals is strengthening the demand for this segment.
• The key industry participants include Brain Corporation (U.S.), CEA Leti (France), General Vision, Inc. (U.S.), Hewlett Packard (U.S.), HRL Laboratories LLC (U.S.), IBM Corporation (U.S.), Intel Corporation (U.S.), Knowm Inc. (U.S.), Numenta, Inc. (U.S.), Qualcomm Inc. (U.S.), and Vicarious FPC, Inc. (U.S.). Industry vendors are emphasizing on product development for new applications and forming technology alliances to gain a competitive edge in the industry.

Key Factors that Drive and Impede the Growth of Newborn Screening Market

The global Newborn Screening Market is expected to reach USD 1.43 billion by 2022, according to a new report by Grand View Research Inc. Increasing occurrence of congenital disorders that lead to mental retardation or dysfunctioning body organs and the availability of advanced screening technologies are expected to drive market growth over the forecast period.

Furthermore, the market is expected to witness a boost in demand owing to, the presence of Federal Bodies involved in organizing awareness and quality assurance programs to imbibe faith and decrease the number of deaths caused due to negligence & non-screening. For instance, in 2011, the Ministry of Health, Japan recommended the use of mass spectrometry in newborn screening and by 2014, the entire nation started utilizing it for 19 critical conditions.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-newborn-screening-market

Further key findings from the report suggest:

• Tandem mass spectroscopy is expected to account for over 25% of newborn screening market share by 2022, owing to its ability to render faster diagnosis and cost effectiveness.
• Pulse oximetry is expected to witness gains of over 9.0% over the forecast period. Masimo’s Eve software and Radical-7 oximeter gained CE marking in 2014 leading to a growth in demand supported by quality assurance and better analysis.
• Dry blood spot test is expected to witness lucrative growth over the forecast period. Free distribution of filter paper by government is expected to boost the primary screening of all newborns, thereby, accelerating market growth.
• Presently, 100% screening of over 4 million neonates is carried out in the North America annually. Encouraging efforts to prevent long term disabilities by healthcare providers and government agencies are some vital factors influencing regional market growth. Presence of favorable reimbursement policies reduces the burden of treatment cost, thereby, promoting higher procedure volumes
• Asia Pacific newborn screening market is expected to witness the fastest growth of over 11.0% during the forecast period. This growth is attributed to the presence of large untapped opportunities, rising healthcare expenditure levels, increasing disease prevalence rate, and the introduction of supportive government initiatives.
• Some key players of this market include Agilent Technologies Inc., AB Sciex LLC, Natus Medical Inc., PerkinElmer Inc., Covidien Plc, Masimo Corp., Trivitron Healthcare, Bio-Rad Laboratories Inc. GE Healthcare and Waters Corp.
• Market participants are constantly engaged in developing technologically advanced products in an attempt to improve presence and ensure sustainability. PerkinElmer’s “EnLite Neonatal TREC Kit” gained FDA approval in 2014 for the diagnosis and treatment of Severe Combined Immunodeficiency Disease (SCID) leading to replacement of non-approved tests in certain states of the U.S.
• Over 20 states along with the Navajo Nation and the District of Columbia have put screening programs into practice for the same.

Non-Invasive Brain Trauma Monitoring Devices Market is growing At a Rapid Pace - Market Analysis and Forecast to 2024

The global Non-Invasive Brain Trauma Monitoring Devices Market is expected to reach USD 15.12 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.

Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.

The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry’s growth.

The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-non-invasive-brain-trauma-monitoring-devices-market

Further key findings from the study suggest:

• Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 60.0% in 2015. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
• The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products. 
• The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 75.0% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth. 
• On the contrary, neurological centers are expected to grow at a sturdy rate over the forecast period. The availability of specialized staff and advanced methodologies are likely to boost the demand for this segment. 
• North America dominated the non-invasive brain trauma monitoring devices market in 2015. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period. 
• Some key players operating in this industry include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Advanced Brain Monitoring, CAS Medical Systems, Inc., Siemens, Compumedics Ltd., Medtronic Plc., and Integra LifeSciences. New product launches, co-developments, and acquisitions are the key initiatives in this industry. 
• For instance, in January 2013, Natus Medical acquired Astro-Med’s products included in monitoring and neurodiagnostic products. This acquisition helped the company to widen the portfolio of EEG systems.